Could this discovery improve heart transplant survival?

The protein haptoglobin boosts inflammation in transplanted hearts, reducing their survival, according to a study led by Yale researchers. The finding may help identify new anti-inflammatory therapies to enhance organ transplant survival.

Inflammation has detrimental effects on the fate of transplanted organs, increasing the risk of rejection. The cause and mechanism that underlies this inflammation is not well understood. To explore pathways leading to inflammation after heart transplantation, Dr. Daniel R. Goldstein, professor of medicine and immunobiology at Yale School of Medicine, and his research team used proteomics, which is the study of protein structure and functions.

Employing mouse models of heart transplantation, the researchers discovered that haptoglobin increased in transplants, triggering inflammation. This enhanced inflammation in turn significantly reduced the long-term survival of cardiac transplants. The researchers also found evidence of haptoglobin in human heart transplant specimens, which suggest their experimental findings may be true in humans, as well.

Given haptoglobin’s complex role in the body, further research is needed to determine whether it should be a target for future therapies. “A larger clinical study will be required to fully appreciate how haptoglobin impacts the fate of organ transplantation in humans,” said Goldstein.

This article is published in collaboration with YaleNews. Publication does not imply endorsement of views by the World Economic Forum.

To keep up with the Agenda subscribe to our weekly newsletter.

Author: Ziba Kashef is a contributing writer for YaleNews.

Image: A nurse poses for a photo in a trauma center of the University of Mississippi Medical Center in Jackson, Mississippi October 4, 2013. REUTERS/Jonathan Bachman.